| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96547e853272614b80b1cabdf8528041 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57488
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb19db25a61e290604c788b06f6a1ac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17cc5d5aba2c99ddf8d506a33986add1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0187ed4279a10efef9047123b8703af0 |
| publicationDate |
2022-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113930515-A |
| titleOfInvention |
Markers and detection kits of chemotherapeutic drug resistance in ovarian cancer |
| abstract |
The present invention discloses markers and detection kits for ovarian cancer chemotherapeutic drug resistance. The markers include CRYAB, CLDN6 and/or CXCL9. The marker of the present invention can predict the curative effect of the chemotherapy regimen before the patient receives chemotherapy, and has good clinical application value. |
| priorityDate |
2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |